Position in ACHV
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$27,930
New position
Shares Held
9,500
first reported quarter
Ownership
0.009%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#62
of 81 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Derivatives in ACHV
reported options exposure · as of Mar 31, 2026CallValue
$391,902
CallShares
133,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SLT Holdings LLC holds $243,608 across 2 Biotechnology names. ACHV ranks #2 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
483 | $215,678 | |
| 2 | ACHV |
Achieve Life Sciences, Inc.
This page
|
9,500 | $27,930 |
All Filings in ACHV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,930 | 9,500 | Shares | Sole | 2026-04-21 | |
| 2026-03-31 | $391,902 | 133,300 | Call | Sole | 2026-04-21 | |
| No filing history on record for this holder in this stock. | ||||||